Adaptive Biotechnologies raises 2025 MRD revenue guidance to $200M as clinical volume accelerates
Source: SeekingAlpha
2025-08-06 02:14:06 ET
More on Adaptive Biotechnologies
- Adaptive Biotechnologies Corporation (ADPT) Q2 2025 Earnings Call Transcript
- Adaptive Biotechnologies GAAP EPS of -$0.17 beats by $0.07, revenue of $58.88M beats by $9.48M
- Seeking Alpha’s Quant Rating on Adaptive Biotechnologies
- Historical earnings data for Adaptive Biotechnologies
- Financial information for Adaptive Biotechnologies
Read the full article on Seeking Alpha
For further details see:
Adaptive Biotechnologies raises 2025 MRD revenue guidance to $200M as clinical volume accelerates
Adaptive Biotechnologies Corporation
NASDAQ: ADPT
ADPT Trading
3.65% G/L:
$12.915 Last:
1,468,501 Volume:
$13.05 Open:
ADPT Latest News
February 05, 2026 04:05:00 pm
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results
January 22, 2026 04:05:00 pm
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
ADPT Stock Data
$2,393,790,148
142,894,616
2.45%
99
N/A
Biotechnology & Life Sciences
Healthcare
US
Seattle
